unknown
Stage
2
Investors
About
Zafrens develops a benchtop high-throughput screening platform that integrates longitudinal cellular imaging with mRNA sequencing at single-cell resolution, enabling large-scale mapping of causal relationships in biology for applications such as drug discovery.
Explore Zafrens's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.